EGFR

You have access
Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of ²²⁵Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models
Christian W. Wichmann, Katherine A. Morgan, Zhipeng Cao, Laura D. Osellame, Nancy Guo, Hui Gan, Edward Reilly, Ingrid J.G. Burvenich, Graeme J. O’Keefe, Paul S. Donnelly and Andrew M. Scott

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1456-1462; DOI: https://doi.org/10.2967/jnumed.123.266894
You have access
Effectiveness of ²²⁵Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR-Positive Kirsten Rat Sarcoma Viral Oncogene and BRAF Mutant Colorectal Cancer Models
Anjong Florence Tikum, Jessica P. Ketchemen, Alireza Doroudi, Anand K. Nambisan, Hanan Babeker, Fabrice Ngoh Njotu and Humphrey Fonge

Journal of Nuclear Medicine March 1, 2024, 65 (3) 402-408; DOI: https://doi.org/10.2967/jnumed.123.266204
You have access
A Phase 1 and Biodistribution Study of ABT-806i, an ¹¹¹In-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806
Hui K. Gan, Matthew Burge, Benjamin Solomon, Sze Ting Lee, Kyle D. Holen, Yumin Zhang, Marika Ciprotti, F.T. Lee, Wijith Munasinghe, JuDee Fischer, Peter Ansell, Gerard Fox, Hao Xiong, Edward B. Reilly, Rod Humerickhouse and Andrew M. Scott

Journal of Nuclear Medicine June 1, 2021, 62 (6) 787-794; DOI: https://doi.org/10.2967/jnumed.120.253146
You have access
Preclinical Evaluation of ¹¹¹In-Labeled PEGylated Maytansine Nimotuzumab Drug Conjugates in EGFR-Positive Cancer Models
Siddesh V. Hartimath, Elahe Alizadeh, Viswas Raja Solomon, Rufael Chekol, Wendy Bernhard, Wayne Hill, Angel Casaco Parada, Kris Barreto, Clarence Ronald Geyer and Humphrey Fonge

Journal of Nuclear Medicine August 1, 2019, 60 (8) 1103-1110; DOI: https://doi.org/10.2967/jnumed.118.220095
Open Access
Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
Thomas A. Burley, Chiara Da Pieve, Carlos D. Martins, Daniela M. Ciobota, Louis Allott, Wim J.G Oyen, Kevin J. Harrington, Graham Smith and Gabriela Kramer-Marek

Journal of Nuclear Medicine March 1, 2019, 60 (3) 353-361; DOI: https://doi.org/10.2967/jnumed.118.216069
You have access
⁶⁴Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor–Expressing Tumors
Ayoung Pyo, Misun Yun, Hyeon Sik Kim, Tae-Yoon Kim, Joong-jae Lee, Jung Young Kim, Sunwoo Lee, Seong Young Kwon, Hee-Seung Bom, Hak-Sung Kim, Dong-Yeon Kim and Jung-Joon Min

Journal of Nuclear Medicine February 1, 2018, 59 (2) 340-346; DOI: https://doi.org/10.2967/jnumed.117.197020
You have access
Cumulated Activity Comparison of ⁶⁴Cu-/¹⁷⁷Lu-Labeled Anti–Epidermal Growth Factor Receptor Antibody in Esophageal Squamous Cell Carcinoma Model
Eric Laffon, Matthieu Thumerel, Jacques Jougon and Roger Marthan

Journal of Nuclear Medicine June 1, 2017, 58 (6) 888-890; DOI: https://doi.org/10.2967/jnumed.116.180521
You have access
Dual-Receptor–Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using ¹⁷⁷Lu- or ¹¹¹In-Labeled Bispecific Radioimmunoconjugates
Eva J. Razumienko, Jason C. Chen, Zhongli Cai, Conrad Chan and Raymond M. Reilly

Journal of Nuclear Medicine March 1, 2016, 57 (3) 444-452; DOI: https://doi.org/10.2967/jnumed.115.162339
You have access
Early Response Monitoring with ¹⁸F-FDG PET and Cetuximab-F(ab′)₂-SPECT After Radiotherapy of Human Head and Neck Squamous Cell Carcinomas in a Mouse Model
Laura K. van Dijk, Otto C. Boerman, Gerben M. Franssen, Jasper Lok, Johannes H.A.M. Kaanders and Johan Bussink

Journal of Nuclear Medicine October 1, 2014, 55 (10) 1665-1670; DOI: https://doi.org/10.2967/jnumed.114.141762
You have access
Molecular Imaging Reveals Trastuzumab-Induced Epidermal Growth Factor Receptor Downregulation In Vivo
Teng Ma, Xianlei Sun, Liyang Cui, Liquan Gao, Yue Wu, Hao Liu, Zhaohui Zhu, Fan Wang and Zhaofei Liu

Journal of Nuclear Medicine June 1, 2014, 55 (6) 1002-1007; DOI: https://doi.org/10.2967/jnumed.114.137000

Main menu

User menu

Search

EGFR

Pages